ATON: results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis. (Q38372931)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ATON: results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis. |
scientific article |
Statements
ATON: results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis (English)
Robert C Sergott
Jeffrey L Bennett
Peter Rieckmann
Daniel Mikol
Ulrich Freudensprung
Thomas Plitz
Johan van Beek